title: Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantation.
authors.affiliation: Liver Transplant Programme, University of Toronto, Ontario, Canada.
authors.forename: P D
authors.initials: PD
authors.lastname: Greig
authors.forename: G
authors.initials: G
authors.lastname: Levy
authors.forename: R A
authors.initials: RA
authors.lastname: Superina
authors.forename: S M
authors.initials: SM
authors.lastname: Strasberg
authors.forename: B R
authors.initials: BR
authors.lastname: Taylor
authors.forename: L M
authors.initials: LM
authors.lastname: Blendis
authors.forename: R
authors.initials: R
authors.lastname: Cameron
authors.forename: M J
authors.initials: MJ
authors.lastname: Phillips
authors.forename: B
authors.initials: B
authors.lastname: Langer
mesh_terms: D000208:Acute Disease; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002648:Child; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins